PAVM - PAVmed Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts2222
Avg. Estimate-0.19-0.18-0.84-0.65
Low estimate-0.21-0.2-1-0.66
High estimate-0.17-0.17-0.69-0.65
Year ago EPS-0.29-0.29-1-0.84
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts4444
Avg. Estimate520k950k3.94M11.51M
Low estimate400k500k1.8M4.6M
High estimate700k1.3M7M19.4M
Year ago salesN/A230k377k3.94M
Sales growth (year/est)N/A313.00%945.10%192.10%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.23-0.26-0.25-0.21
Actual EPS-0.29-0.29-0.23-0.19
Difference-0.06-0.030.020.02
Surprise %-26.10%-11.50%8.00%9.50%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.19-0.18-0.84-0.65
7 days ago-0.19-0.18-0.84-0.65
30 days ago-0.19-0.16-0.78-0.62
60 days ago-0.19-0.16-0.78-0.62
90 days ago-0.21-0.2-0.87-0.75
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 days111N/A
Growth estimatesPAVMIndustrySector(s)S&P 500
Current qtr.34.50%N/AN/AN/A
Next qtr.37.90%N/AN/AN/A
Current year16.00%N/AN/AN/A
Next year22.60%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A